Brain tumour treatment: emerging therapies
Evidence-based neurology checklist on brain tumour treatment: emerging therapies: Tumour treating fields (TTFields) This is an external device with anti-mitotic properties It is used together with chemotherapy Retroviral replicating vector-mediated gene therapies Salinomycin Emerging vaccines…
Tumour treating fields (TTFields)
- This is an external device with anti-mitotic properties
- It is used together with chemotherapy
Retroviral replicating vector-mediated gene therapies
Salinomycin
Emerging vaccines
Other emerging therapies
References
- Wright J, Chugh J, Wright CH, et al. Laser interstitial thermal therapy followed by minimal-access transsulcal resection for the treatment of large and difficult to access brain tumors. Neurosurg Focus 2016; 41:E14.
- Hiraoka K, Inagaki A, Kato Y, et al. Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity. Neuro Oncol 2017; doi: 10.1093/neuonc/nox038 (Epub ahead of print).
- Huang TT, Parab S, Burnett R, et al. Intravenous administration of retroviral replicating vector, Toca 511, demonstrates therapeutic efficacy in orthotopic immune-competent mouse glioma model. Hum Gene Ther 2015; 26:82-93.
- Magrath JW, Kim Y. Salinomycin's potential to eliminate glioblastoma stem cells and treat glioblastoma multiforme (Review). Int J Oncol 2017; 51:753-759.
- Gersey ZC, Rodriguez GA, Barbarite E, et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species. BMC Cancer 2017; 17:99.
- And 7 more. Subscribe to see the full list
